FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.7  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1459292019 Transdermal patch (product) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
1479376011 Transdermal patch en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
2621574015 Patch en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
2660372013 Transdermal patch (qualifier value) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3634739013 Prolonged-release transdermal patch en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch (dose form) Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Some
Prolonged-release transdermal patch (dose form) Is a Drug patch false Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has dose form intended site (attribute) Transdermal (intended site) true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Is a Transdermal dose form (dose form) true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has dose form administration method (attribute) Apply (administration method) true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has dose form transformation (attribute) No transformation true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has dose form release characteristic (attribute) Prolonged-release (release characteristic) true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has basic dose form (attribute) Patch (basic dose form) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely oxybutynin 3.9 milligram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 14 mg/24 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 15 milligram/16 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely rivastigmine 4.6 milligram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely rivastigmine 9.5 milligram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 10 milligram/16 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 21 milligram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 10 milligram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 5 milligram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 15 milligram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 25 microgram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 37.5 microgram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 50 microgram/24 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 60 microgram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 14 microgram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 100 microgram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 80 microgram/24 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 75 microgram/24 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 40 microgram/24 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 50 microgram/24 hour and norethisterone acetate 170 microgram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 50 microgram/24 hour and norethisterone acetate 250 microgram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 50 microgram/24 hour and norethisterone acetate 140 microgram/24 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 45 microgram/24 hour and levonorgestrel 15 microgram/24 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 20 milligram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 5 mg/16 hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 7.5 milligram/24 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some

Start Page 2 of 2

Reference Sets

GB English

US English

Back to Start